The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction

For hundreds of thousands of years, the human genome has extensively evolved, resulting in genetic variations in almost every gene. Immunological reflections of these genetic variations become clearly visible after an allogeneic stem cell transplantation (allo-SCT) as minor Histocompatibility (H) an...

Full description

Bibliographic Details
Main Authors:	Tuna Mutis, Anastasia Xagara, Robbert M. Spaapen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Immunology
Subjects:	minor histocompatibility antigen neoantigen antigen prediction antigen identification reverse antigen identification strategy
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.01162/full

Similar Items

TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
by: Zhan Zhou, et al.
Published: (2017-01-01)

The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy
by: Yae Kye, et al.
Published: (2022-08-01)

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
by: Peng Bai, et al.
Published: (2021-01-01)

Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor
by: Federica Cattina, et al.
Published: (2017-09-01)

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
by: Markus Müller, et al.
Published: (2017-10-01)

Cancer Vaccines: Antigen Selection Strategy
by: Yue Zhao, et al.
Published: (2021-01-01)

Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01)

Frequency of Major Histocompatibility Antigens Class I in Mazandaran Province
by: Fatemeh Toghani Hulari, et al.
Published: (2022-04-01)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
by: Alice Newey, et al.
Published: (2019-11-01)

CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration
by: Jijun Yu, et al.
Published: (2022-05-01)

H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01)

A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
by: Robin Minati, et al.
Published: (2020-12-01)

The Genomic Landscape of Antigenic Targets for T Cell-Based Leukemia Immunotherapy
by: Marie-Pierre Hardy, et al.
Published: (2019-12-01)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
by: Valérie Janelle, et al.
Published: (2020-02-01)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01)

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01)

Tumor antigens and vaccines in colorectal cancer
by: Zhongen Wu, et al.
Published: (2022-12-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
by: Zheying Zhang, et al.
Published: (2021-04-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Minor histocompatibility antigens HA‐8 and PANE1 in the TUNISIAN population
by: Rahma Said, et al.
Published: (2022-11-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
by: Thomas Partridge, et al.
Published: (2018-04-01)

Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
by: Iker Malaina, et al.
Published: (2023-05-01)

Association of human leukocyte antigen with precursor-B acute lymphoblastic leukaemia (pre-B ALL) in Malays
by: Hassan, Norfarazieda
Published: (2013)

TAPBPR mediates peptide dissociation from MHC class I using a leucine lever
by: F Tudor Ilca, et al.
Published: (2018-11-01)

Genetic diversity among volunteer donors of bone marrow in southeastern Brazil, according to the HLA system
by: Letícia Sarni Roque, et al.

ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides
by: Ioannis Temponeras, et al.
Published: (2022-02-01)

Minor Histocompatibility Antigen-Specific T Cells
by: Corinne Summers, et al.
Published: (2020-06-01)

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses
by: Vitaly Kochin, et al.
Published: (2017-04-01)

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen
by: Michael Babich, et al.
Published: (2022-03-01)

The biochemistry of antigen presentation
by: Springer, S, et al.
Published: (1996)

Comparative analysis of minor histocompatibility antigens genotyping methods
by: A. S. Vdovin, et al.
Published: (2016-08-01)

Deciphering the rule of antigen-antibody amino acid interaction
by: Min Jiang, et al.
Published: (2023-12-01)

Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles
by: Katherine V. Gates, et al.
Published: (2017-10-01)

The Association of Myasthenia Gravis with HLA class II Antigens in Iraqi Patients
by: Baghdad Science Journal
Published: (2013-03-01)

Trasplante renal con HLA idéntico de donante vivo y cadavérico: experiencia de la Fundación Valle de Lili, Cali, Colombia
by: Luis Armando Caicedo, et al.

Leishmania spp. proteome data sets: A comprehensive resource for vaccine development to target visceral leishmaniasis
by: Anton eAebischer
Published: (2014-06-01)

Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
by: Tomoyo Shinkawa, et al.
Published: (2021-01-01)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
by: Malte Roerden, et al.
Published: (2019-12-01)

MHC-I genotype drives early immune selection of oncogenic mutations
by: Rachel Marty, et al.
Published: (2018-03-01)

CHARACTER OF DISTRIBUTION OF HLA II ANTIGENS IN PATIENTS WITH AVERAGE AND SEVERE FORMS OF ACNE
by: V. V. Ryabova, et al.
Published: (2018-06-01)